Erratum: Standards of practice: Guidelines for thermal ablation of primary and secondary lung tumors (CardioVascular and Interventional Radiology DOI: 10.1007/s00270-012-0340-1);Standards of practice: Guidelines for thermal ablation of primary and secondary lung tumors

CardioVascular and Interventional Radiology

Volumn 35, Issue 2, 2012, Pages 247-254

  Pereira, Philippe L ^a   Salvatore, Masala ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FLUORODEOXYGLUCOSE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRYOABLATION; FEVER; HEMATOTHORAX; HEMOPTYSIS; HUMAN; HYPERTHERMIA; LABORATORY TEST; LASER THERMOTHERAPY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDICAL HISTORY; MICROWAVE THERAPY; PHYSICAL EXAMINATION; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SECOND CANCER; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84862843507     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0360-x     Document Type: Erratum

References (73)

1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
2. Scott WJ, Howington J, Feigenberg S et al (2007) Treatment of non-small cell lung cancer stage I and stage II. ACCP evidencebased clinical practice guidelines. Chest 132:234-242
3. Crocetti L, Lencioni R (2010) Radiofrequency ablation of pulmonary tumors. Eur J Radiol 75:23-27
4. Tanabe KK, Curley SA, Dodd GD et al (2004) Radiofrequency ablation: the experts weigh in. Cancer 100:641-650
5. Berber E, Pelley R, Siperstein AE (2005) Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23:1358-1364
6. Livraghi T, Solbiati L, Meloni F et al (2003) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the ''test-of-time approach''. Cancer 97: 3027-3035
7. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201-1209
8. Gillams A (2007) Minimally invasive treatment for liver and lung metastases in colorectal cancer. Br Med J 334:1056-1057
9. Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159-166
10. Rosenthal DI, Hornicek FJ, Torriani M et al (2003) Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 229:171-175
11. Livraghi T, Solbiati L, Meloni MF et al (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226: 441-451
12. Gervais DA, McGovern FJ, Arellano RS et al (2003) Renal cell carcinoma: clinical experience and technical success with radiofrequency ablation of 42 tumors. Radiology 226:417-424
13. Dupuy DE, Zagoria RJ, Akerley W et al (2000) Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 174:57-59
14. De Baere T, Palussiere J, Auperin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587-596
15. Hiraki T, Sakurai J, Tsuda T et al (2006) Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 107:2873-2880
16. Sano Y, Kanazawa S, Gobara H et al (2007) Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 109:1397-1405
17. Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268-275
18. Rose SC (2008) Radiofrequency ablation of pulmonary malignancies. Semin Respir Crit Care Med 29:361-383
19. Wang H, Littrup PJ, Duan Y et al (2005) Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 235:289-298
20. Rosenberg C, Puls R, Hegenscheid K et al (2009) Laser ablation of metastatic lesions of the lung: long term outcome. AJR Am J Roentgenol 192:785-792
21. Wolf FJ, Grand DJ, Machan JT et al (2008) Microwave ablation of lung malignancies: effectiveness, CT-findings, and safety in 50 patients. Radiology 247:871-879
22. Van Cutsem EJ, Oliveira J (2008) Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(33):34
23. Greaves SM, Brown K, Garon EB, Garon BL (2011) The new staging system for lung cancer: imaging and clinical applications. J Thorac Imaging 26:119-131
24. Shim SS, Lee KS, Kim BT et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET-CT and CT alone for preoperative staging. Radiology 236:1011-1019
25. Dupuy DE (2011) Image-guided thermal ablation of lung malignancies. Radiology 260:633-655
26. Rose SC, Damian DE, Gervais DA, Technology Assessment Committee of the Society of Interventional Radiology Research et al (2009) Reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol 20:474-485
27. Gomez FM, Palussiere J, Santos E et al (2009) Radiofrequency thermocoagulation of lung tumors. Where we are, where we are headed. Clin Transl Oncol 11:28-34
28. Kang S, Luo R, Liao W et al (2004) Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post-treatment positron emission tomography in lung tumours. World J Surg Oncol 2:30-36
29. Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radiofrequency ablation for inoperable NSCLC and metastases: preliminary report. Radiology 230:125-134
30. Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE (2009) Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254:301-307
31. Lencioni R, Crocetti L, Cioni R et al (2008) Response to radiofrequency ablation of pulmonary tumors: a prospective intentionto- treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9:621-628
32. Dupuy DE, DiPetrillo T, Gandhi S et al (2006) Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 129:738-745
33. DeBaere T (2011) Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Interv Radiol 34:241-251
34. Chua TC, Glenn D, Morris DL (2010) Extending the survival of patients with melanoma lung metastases through radiofrequency ablation. Acta Oncol 49:517-519
35. Hiraki T, Yamakado K, Ikeda O et al (2011) Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan. J Vasc Interv Radiol 22:741-748
36. Fernando HC, Hoyos HD, Little V et al (2004) Radiofrequency ablation: identification of the ideal patient. Clin Lung Cancer 6:149-153
37. Palussiere J, Italiano A, Descat E et al (2011) Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients. Ann Surg Oncol 18:371-377
38. Nakamura T, Matsumine A, Yamakado K et al (2009) Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas. Cancer 115:3774-3781
39. Sano Y, Kanazawa S, Mimura H et al (2008) A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery. J Thorac Oncol 3:283-288
40. Chua TC, Thornbury K, Saxena A et al (2010) Radiofrequency ablation as an adjunct to systemic therapy for colorectal pulmonary metastases. Cancer 116:2106-2114
41. Patel IJ, Davidson JC, Nikolic B et al (2009) Consensus guidelines for periprocedural management of coagulation. Status and hemostasis risk in percutaneous image guided interventions. J Vasc Interv Radiol 20:240-249
42. Hoffmann RT, Jakobs TF, Lubienski A et al (2006) Percutaneous radiofrequency ablation of pulmonary tumors-is there a difference between treatment under general anesthesia and under conscious sedation? Eur J Radiol 59:168-174
43. Steinke K, King J, Glenn D et al (2003) Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 27:750-757
44. Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Interv Radiol 32:478-483
45. Clasen S, Kettenbach J, Kosan B et al (2009) Delayed development of pneumothorax after pulmonary radiofrequency ablation. Cardiovasc Interv Radiol 32:484-490
46. Gillams AR, Lees WR (2008) Radiofrequency ablation of lung metastases: factor influencing success. Eur Radiol 18:672-677
47. Iguchi T, Hiraki T, Gobara H et al (2007) Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol 18: 733-740
48. Palussiere J, Marcel B, Descat E et al (2011) Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Interv Radiol 34:989-997
49. Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 18: 399-404
50. Deandreis D, Leboulleux S, Dromain C et al (2011) Role of FDG PET-CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology 258:270-276
51. Yoo DC, Dupuy DE, Hillman SL et al (2011) Radiofrequency ablation of medically inoperable stage Ia non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? AJR Am J Roentgenol 197:334-340
52. Pereira PL, Trubenbach J, Schenk M et al (2004) Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 232:482-490
53. Rhim H, Goldberg SN, Dodd GD 3rd et al (2001) Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 21:17-39
54. Clasen S, Schmidt D, Dietz K et al (2007) Bipolar radiofrequency ablation using internally cooled electrodes in ex vivo bovine liver: prediction of coagulation volume from applied energy. Invest Radiol 42:29-36
55. Gage AA, Baust J (1998) Mechanisms of tissue injury in cryosurgery. Cryobiology 37:171-186
56. Bellman S, Ray JA (1956) Vascular reactions after experimental cold injury. Angiology 7:339-367
57. Wang H, Littrup PJ, Duan Y et al (2005) Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 235:289-298
58. Hinshaw JL, Durick NA, Leung W et al (2009) Radiology- pathology correlation of pulmonary cryoablation in a porcine model. J Interv Oncol 2:113-120
59. Skinner MG, Lizuka MN, Kolios MC et al (1998) A theoretical comparison of energy sources-microwave, ultrasound and laser-for interstitial thermal therapy. Phys Med Biol 43: 3535-3547
60. Brace CL, Hinshaw JL, Laeseke PF et al (2009) Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using cross pathologic and CT findings in a swine model. Radiology 251:705-711
61. Zhu JC, Yan TD, Morris DL (2008) A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 15:1765-1774
62. Yamakado K, Inoue Y, Takao M et al (2009) Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 22:885-891
63. Kodama H, Yamakado K, Takaki H et al (2011) Lung radiofrequency ablation for the treatment of unresectable recurrent nonsmall- cell lung cancer after surgical intervention. Cardiovasc Interv Radiol. doi:10.1007/s00270-011-0220-0
64. Shu Yan Huo A, Lawson D, King J, Glenn D (2009) Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol 16:3169-3175
65. Soga N, Yamakado K, Gohara H et al (2009) Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma. Br J Urol Int 104:790-794
66. Choe YH, Kim SR, Lee KS et al (2009) The use of PTC and RFA as treatment alternatives with low procedural morbidity in nonsmall cell lung cancer. Eur J Cancer 45:1773-1779
67. Hiraki T, Gobara H, Mimura H et al (2010) Does tumor type affect local control by radiofrequency ablation in the lungs? Eur J Radiol 74:136-141
68. Grieco CA, Simon CJ, Mayo-Smith WW et al (2006) Percutaneous image guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 17: 1117-1124
69. Yan TD, King J, Sjarif A et al (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13: 1529-1537
70. Vogl T, Naguib NNN, Gruber-Rouh T et al (2011) Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology 261:643-651
71. Sacks D, McClenny TE, Cardella JF, Lewis CA (2005) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:199-202
72. Steinke K (2008) Radiofrequency ablation of pulmonary tumours: current status. Cancer Image 8:27-35
73. Hiraki T, Tajiri N, Mimura H et al (2006) Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 241: 275-283